SIRT6 and neoplasm: Transcriptomic analyses of the gastric inflammation-carcinoma sequence reveal stage-specific SIRT6 activity, with peak expression during intestinal metaplasia and evidence of tumor-suppressive effects through inhibition of cell proliferation and migration [77,93].